Freeze drying with collapse is not necessarily bad for stability and can reduce cost

Lyophilization is often used to increase the stability and shelf life of proteins which are physically and/or chemically unstable in aqueous solution. Freeze drying removes water protein solutions, including water from the protein surface which plays a major role within the protein structure, and this frequently causes damage. An appropriate choice of stabilising additives is necessary to protect the protein from the denaturing during both the freezing and the dehydration. The components of the excipients displace water by replacement, which makes the drying possible without causing damages to the proteins. In addition the solidification of the excipients forms a matrix around the particles which keeps the protein in their native structures.

Freeze drying

 

Concerning the process, the cycle is usually running below collapse temperature to avoid a loss of physical structure, an incomplete drying (high moisture content), a decrease of solubility (or increase of aggregation), or a decrease of activity and/or stability. In addition, the best freeze drying cycles are those that have been optimised to be as short as possible: run at high temperature to run fast. In that case, formulation should have a high glass transition temperature to facilitate freeze drying. Some disaccharides like sucrose are often good stabilisers for proteins but unfortunately they have a low collapse temperature.
Recent studies seem to indicate that drying above the collapse temperature is not necessarily bad; the protein stability is not always damaged. Our objective was to
study the activity and stability of a freeze dried protein in vials which shows signs of collapse. The protein selected was the alkaline phosphatase (from Sigma Aldrich) which is used to help detecting liver disease. The enzyme may catalyse the hydrolysis of various monophosphate esters at alkaline pH, the method for the measurement of alkaline phosphatase specific activity was based on the conversion of para-nitrophenylphosphate (p-NPP) to para-nitrophenol and the colorimetric determination of the resulting coloured product.
A formulation by combining alkaline phosphatase, Tris HCL buffer and sucrose was defined. The collapse temperature (Tcoll) was measured using freeze drying microscopy (cf. figure 1)

 

Freeze drying : microscopic observation

 

The formulation was poured into a vial and loaded in a freeze drier. Two cycles were running: one with a “conservative” freeze drying protocol which maintains the product temperature below collapse temperature (time of cycle : 72 hours, cf. figure 2) and an “aggressive” freeze drying protocol carried out at higher temperature and higher pressure which does not maintain the product temperature below collapse temperature (time of cycle : 48 hours, cf. figure 3).

 

Freeze drying : conservative and agressive cycles

 

In the first case the appearance of the freeze dried products were good, in the second case they showed signs of collapse but the cycle was shorter (cf. figure 4).
These measurements are performed in accordance with a TO and after storage at a 25°C temperature conditions. The results of storage stability in dried state (cf. figure 5) confirm that sucrose stabilizes the protein conformation against denaturing but more particularly the results suggest that the freeze dried product with signs of collapse did not damage the alkaline phosphatase quality. The specific activity recovery of alkaline phosphatase is quite the same with a collapse macroscopic structure than with none.

 

Freeze drying : macroscopic view of freeze dried formulation

 

Freeze drying : specific activity recovery of alkaline phosphatise

 

This presentation is for informational purposes only and it is not about new guidelines for stabilization of proteins by freeze drying but it suggests that in some cases, not generally speaking, we can freeze dry above the collapse temperature to have a short cycle which implies lower costs without causing damages to the product if we do not care to have a not elegant product, if the product aspect is not that important.

Capture D’écran 2017 12 06 à 16.48.31

Sophie DECLOMESNIL – LYOFAL

Dr Sophie Declomesnil is the manager of Research and Development at LYOFAL (SYNERLAB group) leading collaborative research activity of client projects. Over the past 19 years, she has been working at Lyofal and is responsible for the lyophilisation development of the company focusing on formulation, freeze drying cycle development and thermal properties of the products and also tech transfer. After graduating in science and engineering in the graduate Agrosup DIJON, a French National Institute of technology for Life, Food and Environmental Sciences, she received a Doctorate in Biotechnology

sophie.declomesnil@synerlab.com

Partager l’article

LinkedinEnvoyer par mail